Privia Health Group, Inc. — Form 8-K Summary
Business context and reporting period
Privia Health Group, Inc. filed this Form 8-K regarding its 2022 Annual Meeting of Stockholders, held via live webcast on May 11, 2022. The filing was signed on May 13, 2022. Of 108,189,603 shares outstanding and entitled to vote, 87,183,571 shares were represented in person or by proxy.
Key financial metrics and capital structure
This filing reports corporate governance matters and does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating or financial performance metrics.
Material changes versus the prior comparable period
The filing text does not report material changes in financial performance, operations, capital structure, or business outlook versus a prior period.
Meeting outcomes, outlook, and risks
- Stockholders elected all ten director nominees to serve until the 2023 Annual Meeting or until their successors are elected and qualified, or their earlier death, resignation, or removal.
- Votes for the elected directors ranged from 73,978,954 to 86,242,061; each nominee also received 894,712 broker non-votes.
- Stockholders ratified PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022, with 87,182,354 votes for, 435 against, and 782 abstentions.
- The filing provides no management guidance, operating outlook, contingencies, unusual items, or risk-factor updates.
Investor verification points
- Verify the final composition and tenure of the board following the annual meeting.
- Confirm PricewaterhouseCoopers LLP’s appointment as independent registered public accounting firm for fiscal 2022.
- Review the Company’s periodic financial filings separately for financial performance, liquidity, debt, guidance, and risk information not included in this Form 8-K.